Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity ...

After years of preparation, Eli Lilly is on the brink of launching ... The Tempo pen is currently compatible with three of Lilly's insulin products, including Humalog and Lyumjev, both insulin ...

Eli Lilly and Company (NYSE:LLY), a leading global pharmaceutical firm, finds itself at a pivotal juncture as it navigates a ...

DBS analyst Nico Chen has maintained their bullish stance on LLY stock, giving a Buy rating on January 21.Invest with Confidence: Follow ...

Eli Lilly (LLY) shares traded down ... as well as a number of upcoming catalysts." Lilly expects its most-watched blockbuster products — GLP-1 tirzepatide products Mounjaro and Zepbound ...

As expected by many, Eli Lilly And Co (NYSE:LLY) filed a motion to intervene as a defendant in a case between the Outsourcing Facilities Association and FarmaKeio Custom Compounding against the FDA.